Supernus Pharmaceuticals Statistics
Total Valuation
SUPN has a market cap or net worth of $1.79 billion. The enterprise value is $1.37 billion.
| Market Cap | 1.79B |
| Enterprise Value | 1.37B |
Important Dates
The last earnings date was Tuesday, February 25, 2025, after market close.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SUPN has 55.81 million shares outstanding. The number of shares has increased by 0.81% in one year.
| Current Share Class | 55.81M |
| Shares Outstanding | 55.81M |
| Shares Change (YoY) | +0.81% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 4.38% |
| Owned by Institutions (%) | 100.18% |
| Float | 48.52M |
Valuation Ratios
The trailing PE ratio is 24.23 and the forward PE ratio is 16.29.
| PE Ratio | 24.23 |
| Forward PE | 16.29 |
| PS Ratio | 2.66 |
| Forward PS | 2.79 |
| PB Ratio | 1.72 |
| P/TBV Ratio | 4.50 |
| P/FCF Ratio | 10.43 |
| P/OCF Ratio | 10.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.64, with an EV/FCF ratio of 7.98.
| EV / Earnings | 18.50 |
| EV / Sales | 2.06 |
| EV / EBITDA | 9.64 |
| EV / EBIT | 22.27 |
| EV / FCF | 7.98 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.35 |
| Quick Ratio | 2.04 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.20 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.55% and return on invested capital (ROIC) is 3.77%.
| Return on Equity (ROE) | 7.55% |
| Return on Assets (ROA) | 2.90% |
| Return on Invested Capital (ROIC) | 3.77% |
| Return on Capital Employed (ROCE) | 5.70% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | $113,290 |
| Employee Count | 652 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.18 |
Taxes
In the past 12 months, SUPN has paid $24.01 million in taxes.
| Income Tax | 24.01M |
| Effective Tax Rate | 24.53% |
Stock Price Statistics
The stock price has increased by +4.44% in the last 52 weeks. The beta is 0.84, so SUPN's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +4.44% |
| 50-Day Moving Average | 36.72 |
| 200-Day Moving Average | 33.06 |
| Relative Strength Index (RSI) | 33.10 |
| Average Volume (20 Days) | 687,329 |
Short Selling Information
The latest short interest is 5.72 million, so 10.24% of the outstanding shares have been sold short.
| Short Interest | 5.72M |
| Short Previous Month | 5.74M |
| Short % of Shares Out | 10.24% |
| Short % of Float | 11.78% |
| Short Ratio (days to cover) | 16.89 |
Income Statement
In the last 12 months, SUPN had revenue of $661.82 million and earned $73.87 million in profits. Earnings per share was $1.32.
| Revenue | 661.82M |
| Gross Profit | 583.91M |
| Operating Income | 61.36M |
| Pretax Income | 37.42M |
| Net Income | 73.87M |
| EBITDA | 141.77M |
| EBIT | 61.36M |
| Earnings Per Share (EPS) | $1.32 |
Balance Sheet
The company has $453.61 million in cash and $34.27 million in debt, giving a net cash position of $419.34 million or $7.51 per share.
| Cash & Cash Equivalents | 453.61M |
| Total Debt | 34.27M |
| Net Cash | 419.34M |
| Net Cash Per Share | $7.51 |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | 18.58 |
| Working Capital | 393.67M |
Cash Flow
In the last 12 months, operating cash flow was $171.95 million and capital expenditures -$725,000, giving a free cash flow of $171.23 million.
| Operating Cash Flow | 171.95M |
| Capital Expenditures | -725,000 |
| Free Cash Flow | 171.23M |
| FCF Per Share | $3.07 |
Margins
Gross margin is 88.23%, with operating and profit margins of 9.27% and 11.16%.
| Gross Margin | 88.23% |
| Operating Margin | 9.27% |
| Pretax Margin | 14.79% |
| Profit Margin | 11.16% |
| EBITDA Margin | 21.42% |
| EBIT Margin | 9.27% |
| FCF Margin | 25.87% |
Dividends & Yields
SUPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.81% |
| Shareholder Yield | -0.81% |
| Earnings Yield | 4.14% |
| FCF Yield | 9.59% |
Analyst Forecast
The average price target for SUPN is $36.00, which is 12.54% higher than the current price. The consensus rating is "Hold".
| Price Target | $36.00 |
| Price Target Difference | 12.54% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 7.14% |
| EPS Growth Forecast (5Y) | 31.04% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUPN has an Altman Z-Score of 4.65 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.65 |
| Piotroski F-Score | 7 |